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ABSTPACT 
Peri ventricular-intraventricular hemorrhage (PV-
IVH) is a serious form of neonatal intracranial 
hemorrhage. This research was undertaken to determine 
the relationship between PV-IVH and hyperglycemia. 
Medical records of 57 preterm infants from the 
University of Utah Medical Center were examined. 
Data collected demonstrated a significant relationship 
between the occurrence of a PV-IVH and a hyperglycemia 
episode. The severity of hyperglycemia could not 
predict the development of hydrocephalus. 
It was concluded that the clinical value of 
glucose determinations may serve to identify a PV-IVH. 
Further research is indicated to validate these 
findings and to define the specifics of the relation-
ship between these variables. 
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CHAPTER I 
INTRODUCTION 
Peri ventricular-intraventricular hemorrhage (PV-
IVH) is a common and serious form of neonatal intra-
cranial hemorrhage for which there is no definite 
method of prevention or treatment (Cooke, 1981; 
de Court en & Rabinowicz, 1981; Fujimura, Salisbury, 
Robinson, Howatt, Emerson, Keeling & Tizard, 1979; 
Hambleton & Wigglesworth, 1976; Lazzara, Ahmann, Dykes, 
Brann & Schwartz, 1980; Wigglesworth & Pape, 1980). 
The development of perinatal - neonatal regionali-
zation (Brown, 1980; Green, 1980) has resulted in 
dramatic improvement in survival rates of small 
premature infants. Because periventricular-intraventri-
cular hemorrhage (PV-IVH) is a characteristic compli-
cation of preterm infants less than or equal to 32 
weeks gestation (Cooke, 1981; de Courten & Rabinowicz, 
1981; Hambleton & Wigglesworth, 1976; Towbin, 1968; 
Volpe, 1981; Wigglesworth & Pape, 1980), its incidence 
has increased with the increasing survival rate of this 
gestational age group. In the past 20 years, infant 
mortality resulting from hyaline membrane disease has 
markedly decreased (Krauss, 1980), whereas the death 
rate for peri ventricular-intraventricular hemorrhage 
(PV-IVH) has remained almost constant (Anderson, 1977; 
Robinson & Desai, 1981). 
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PV-IVH is characterized by hemorrhage into the 
region of the terminal vein of the subependymal 
germinal matrix. The hemorrhage can remain isolated 
or rupture through the ependyma and into the ventri-
cular system (Papile, Burstein, J., Burstein, R., & 
Koffler, 1978; Volpe, 1981; Wigglesworth & Pape, 1980). 
The reported incidence of hemorrhages affecting the 
subependymal region, with or without spread into the 
ventricles, are between 35 and 50% (Ahmann, Lazzara, 
Dykes, Brann & Schwartz, 1980; Leech & Kohnen, 1974; 
Levene, Fawer, and Lamont, 1982; Papile et al., 1978; 
Shinnar, Molteni, Gammon, D'Souza, Altman & Freeman, 
1982). The mortality rate from PV-IVH ranges between 
17 to 55% (Ahmann et al., 1980; Papile et al., 1978; 
Shinnar et al., 1982), with the overall incidence of 
fatal PV-IVH reported as being between one and two 
point five per one thousand live births (Anderson, 
1977; Schoenberg, Mellinger & Schoenberg, 1977). The 
significance of posthemorrhagic hydrocephalus and 
longterm neurologic sequelae are currently under 
study (Papile et al., 1978; Shinnar et al., 1982). 
The reported morbidity from these entities, thus far, 
range from 2 to 29% (Ahmann et al., 1980; Robinson & 
Desai, 1981; Shinnar et al., 1982). 
Although this neurologic complication can be 
associated with a number of features, (e.g., an 
unexplained fall in hematocrit and/or its failure to 
rise following a blood transfusion, an increase in 
the tenseness of the anterior fontanel, and changes in 
the cardiorespiratory status) PV-IVH is not always 
clinically apparent (Fujimura et al., 1979; Lazzara 
et al., 1980; Volpe, 1981). Investigation for a more 
sensitive and objective clinical sign of impending 
PV-IVH would facilitate the identification of the 
onset of hemorrhage. Pinpointing the time of occur-
rence may result in clinical interventions which may 
decrease the incidence or severity of PV-IVH. 
This investigator has noted that an apparent 
rise in serum glucose concentration as determined by 
Dextrosti~(MOSS, 1968), precipitates the onset of the 
clinical signs of PV-IVH. This is the basic premise 
for this study. 
Problem 
The problem of the study was to identify if a 
relationship exists between the development of hyper-
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glycemia and the occurrence of PV-IVH in the preterm 
infant. 
Purpose 
The purpose of this study was to determine the 
relationship between the onset of PV-IVH and the 
occurrence of hyperglycemia. If a relationship can 
be demonstrated, future research may be indicated to 
identify the specific care that could decrease the 
severity of PV-IVH. Ultimately, it is hoped that this 
endeavor will uncover clinical information which will 
facilitate a more rapid identification of a PV-IVH. 
The identification of a clinical tool to improve the 
observational and bedside care of infants at risk for 
a PV-IVH would be a significant contribution to the 
field of nursing. 
conceptual Framework 
Abbey (1978) described a general systems theory 
on which this study's conceptual framework is based. 
She introduced the concept that all systems are 
organized units composed of mutually-reacting 
components and interacting forces. In response to 
various stresses and strains imposed upon the system, 
feedback circuits guide an internal reorganization 
in order to maintain an intact system. There are two 
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types of systems: closed and open. The closed system 
consists of variables that react with a predictable 
outcome. In contrast, the open system consists of 
variables that react in a continuous, orderly fashion, 
where the outcome is unpredictable due to the infinite 
number of variables. 
The system, as a whole, experiences disorgani-
zation and a loss of energy, in response to a dysfunc-
tion of a part. Only the replacement of this lost 
energy will insure survival of the system whether open 
or closed (Abbey, 1978). 
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Man entering into an exchange with his environment 
is an example of an open system. The human body is 
an example of a closed system. The mutually reacting 
components of man are the various subsystems such as 
the glucose homeostatic mechanism. The components of 
this subsystem are the cells. The hormones and enzymes 
make up the feedback circuits which guide the system 
to glucose homeostasis. Components used to regulate 
serum glucose concentration are glucose supply, 
glucose utilization, and hepatic function. A change 
in anyone of these components predictably affects 
blood glucose levels. Energy lost in the process of 
glucose homeostasis must be replaced by providing 
nutrients for energy in order for the system to survive. 
When a system disturbance occurs, the general 
systems theory recognized nursing as having the 
potential "to facilitate energy transfer ... that is 
needed by a system to preserve its self" (Abbey, 1978, 
p. 23). However, the nurse must first be able to 
recognize the stress and the potential strain the 
disturbance will cause before transferring energy 
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back to the system, in order to preserve a homeostatic 
self. In this study, the research hoped to demonstrate 
that a disturbance, hyperglycemia, caused by a 
preceding stressful event (i.e., hypothermia, pneumo-
thoraces, or even a PV-IVH), might serve as a sign of 
a recent or even an impending PV-IVH. Frequent 
measurement of glucose levels during the time of 
greatest occurrence of PV-IVH may give health care 
providers the opportunity to pinpoint the occurrence 
or give warning to a new or impending PV-IVH. Once 
alerted, initiation of therapy based on further 
diagnostic examination might be facilitated. 
CHAPTER II 
REVIEW OF LITERATURE 
Glucose Homeostasis 
Glucose is the primary fuel source of the neonate. 
It sustains the energy required for cellular metabolism. 
Specific organs and tissues have varying ability to 
utilize other substrates for energy during periods of 
fasting. Peripheral tissues such as muscle and fat 
can effectively curtail their glucose utilization 
(Cowett, Oh, Pollak, Schwartz & Stonestreet, 1979). In 
contrast, obligate glucose utilizing tissues such as 
the brain, peripheral nerves, blood components, bone 
marrow, and renal medulla continue to use glucose as 
their primary fuel source regardless of the serum 
glucose concentration (Greenberg, 1973). Although 
ketones, glycerol and lactate can support cerebral 
metabolism during periods of extreme hypoglycemia, the 
brain, a rapidly and highly perfused organ, requires 
a minute-to-minute supply of glucose. The major 
portion of basal hepatic glucose output goes to the 
maintenance of cerebral metabolism (Cornblath & 
Schwartz, 1976; Greenberg, 1973). 
Serum glucose concentration reflects the dynamic 
equilibrium between peripheral glucose utilization and 
hepatic glucose production. In turn, a number of 
factors determine the capacity of the liver to 
release glucose into the hepatic vein: 
1. Extent of preformed glucose stores. 
2. State of multienzyme systems which facilitate 
glucose production. 
3. Secretion of hormones which regulate the rate 
of glucose production from other substrates. 
4. Availability of substrates (derived largely 
from peripheral tissues) (Greenberg, 1973). 
A basic appreciation of these metabolic processes 
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is necessary in order to understand glucose homeostasis. 
Glucose Transport and 
Phosphorylation 
The mechanism by which glucose is transported 
across cell membranes and also transplacentally is 
facilitated diffusion (Guyton, 1977; Haymond & 
Pagliara, 1979). This type of diffusion allows move-
ment of molecules from an area of higher concentration 
to one of lower concentration at a faster rate than 
would be predicted on just a physical basis. The 
diffusion is "facilitated ll in that a given substance 
(glucose) combines with a carrier substance in the 
cell membrane and this carrier-substrate complex 
crosses the membrane faster than the substrate alone. 
Insulin facilitates this transmembrane movement of 
glucose. 
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Quantitatively, there is a maternal-to-fetal 
transfer of approximately six mg/kg/min (fetal weight) 
of glucose (Haymond & Pagliara, 1979). This maintains 
the fetal blood glucose concentration in the range of 
70-80% of maternal serum values (Cornblath & Schwartz, 
1976; Cowett et al., 1979; Miranda & Dweck, 1977). In 
comparison, the term neonate has a reported basal 
hepatic output of approximately six to eight mg/kg/ 
minute (Adams, King & Schwartz, 1968; Cowett et al., 
1979). In the adult, endogenous hepatic glucose 
production is closer to two to four mg/kg/minute 
(Cornblath & Schwartz, 1976). 
Whether the source of glucose is endogenous or 
exogenous, it must rst be intracellularly trans-
formed into a more useful form (glucose-six-phosphate) 
in a process called phosphorylation. Two enzyme 
systems catalyze this process: a) glucokinase, which 
is present only in the liver and is insulin dependent, 
and b) hexokinase, which is present in the liver and 
all other tissues and is insulin independent. The 
phosphorylation of glucose is almost completely 
irreversible except in liver, renal and intestinal 
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epithelial cells in which specific phosphatases exist 
that can reverse this process (Guyton, 1977). This 
presumably accounts for the relative stability of the 
otherwise diffuseable intracellular glucose molecule. 
The fetal and neonatal liver differs from that of 
the adult in that hexokinase is the only phosphorylating 
enzyme present (Adams, 1971). With the limited maximum 
catalyzing capacity of hexokinase and the absence of 
glucokinase, there is a relatively small, but constant 
glucose uptake and storage in the fetal and neonatal 
liver. This could account for the fact that glucose 
uptake occurs in this population even in the absence of 
significant insulin responses to a glucose load (Cowett, 
Susa, Oh & Schwartz, 1978; Fisher, Arrington & Beard, 
1977; Pollak, Cowett, Schwartz & Oh, 1978; Varma, 
Nickerson, Cowan & Hetenyi, 1973). 
After phosphorylation, glucose can be utilized via 
three major pathways: 
1. The glycolytic pathway: an immediate energy 
source. 
2. The glycogenesis-glycogenolysis pathway: a 
stored energy source. 
3. The gluconeogenic pathway: a basis for the 
synthesis of glucose from noncarbohydrate 
sources (Adams, 1971; Guyton, 1977; Stanley, 
1981) . 
Glycolysis 
Glycolysis is the intracellular process which 
converts glucose into an immediate energy source in 
the form of ATP (adenosine triphosphate). Glucose-
six-phosphate is phosphorylated into fructose-six-
phosphate, which then undergoes several successive 
steps of chemical reactions, each step catalyzed by 
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at least one specific protein enzyme (Figure 1). The 
end product, after the release of energy, is dependent 
on the availability of oxygen. In the presence of 
oxygen, glucose releases energy and pyruvic acid. 
When oxygen is unavailable or insufficient, a small 
amount of energy can still be released through glycoly-
sis, resulting in energy and lactic acid. Of the two 
methods, the aerobic degradation of glucose is much 
more energy efficient than the anaerobic pathway 
(Guyton, 1977). 
Glycogenesis-Glycogenolysis 
Glycogen is the storage form of glucose produced 
in a process known as glycogenesis. Early in human 
gestation, the pattern of glycogen metabolism varies 
from tissue to tissue. The liver, a primary neonatal 
storage site for glycogen (Cornblath & Schwartz, 1976; 
Miranda & Dweck, 1977), appears to be a major source 
of glucose during the time immediately following birth. 
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Figure 1. Pathways of glucose metabolism. 
Adapted from Ganong, 1977. 
12 
A variety of hormones is involved in glucose 
homeostasis. Glucagon is produced by the alpha cells 
of the pancreatic islets of Langerhans in response to 
low glucose levels in the blood perfusing the alpha 
cells. Epinephrine is a catecholamine released by 
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the adrenal medulla, particularly during times of 
stress. Both of these hormones have been demonstrated 
to stimulate adenyl cyclase activity which increases 
the concentration of cyclic AMP, and activates protein 
kinase in the liver cells (Guyton, 1977). The end 
result of this cascade of events is the activation of 
phosphorylase, the enzyme facilitating glycogenolysis, 
and the inactivation of glycogen synthetase, the 
enzyme needed for glycogenesis (Adams, 1971; Cornblath 
& Schwartz, 1976; Haymond & Pagliara, 1979; Stanley, 
1981) . 
Glycogenolysis involves glycogen metabolism into 
glucose-six-phosphate which can be utilized for energy 
via the glycolysis pathway. This mechanism of glycogen 
degradation can only occur in the liver, kidney and 
intestines which contain the necessary enzymes for 
breakdown (Guyton, 1977; Haymond & Pagliara, 1979). 
Insulin is a hormone which stimulates glycogenesis 
by inactivating phosphorylase and activating glycogen 
synthetase. Insulin accomplishes this task by antago-
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nizing the effect of glucagon, epinephrine, and cyclic 
AMP on hepatic glycogen metabolism. The beta cells of 
the pancreatic islets of Langerhans secrete insulin 
in response to elevated blood glucose levels. Glucose 
diffusion into the cell is "facilitated" by insulin in 
various tissues such as the muscle, connective and 
adipose tissue. In the liver, however, glucose 
transport can occur independent of circulating insulin 
levels (Guyton, 1977; Haymond & Pagliara, 1979). 
Glucose-six-phosphate is converted into glycogen 
through a series of enzymatically controlled steps and 
stored in the liver, heart, skeletal muscle and adipose 
tissue (Cornblath & Schwartz, 1976). 
Gluconeogenesis 
Neonatal glycogen stores are rapidly mobilized and 
are largely depleted within a few hours following birth -' 
to meet newly acquired extrauterine needs (i.e., 
muscular activity, temperature, respiratory and 
metabolic regulation) (Greenberg, 1973; Miranda & 
Dweck, 1977). For the premature and, particularly the 
smal for-gestational age (SGA) infant, availability of 
glucose from their limited glycogen stores are reduced. 
Infants, especially when growth retarded and/or 
subjected to perinatal/neonatal stress, must sustain 
a relatively increased basal hepatic glucose output 
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(Miranda & Dweck, 1977). Following the depletion of 
glycogen stores, the supply of glucose by the liver is 
dependent on gluconeogenesis (Adams, 1971; Haymond & 
Pagliara, 1979; Stanley, 1981). 
The pathway for the synthesis of glucose from 
various other substrates is present in the liver, 
kidney and intestines (Stanley, 1981). The liver is 
the major organ of gluconeogenesis using lactate, 
glycerol and amino acids (alanine) as the precursors 
for glucose production. The rate of gluconeogenesis 
in the liver is stimulated by glucagon, catecholamine 
and glucocorticoids and inhibited by insulin. Only 
after prolonged fasting is the kidney's importance as 
a gluconeogenic organ realized. In the kidney, the 
amino acid glutamine replaces alanine as an important 
precursor for glucose (Haymond & Pagliara, 1979; 
Stanley, 1981). During nonacidotic conditions, the 
small intestines absorb glutamine released by skeletal 
muscles. The small intestines in vivo utilizes 
glutamine as its own respiratory substrate as well as 
converting it into alanine for hepatic gluconeogenesis 
(Stanley, 1981). 
Hyperglycemia 
While the frequency and clinical importance of 
hypoglycemia has been well documented, the incidence 
16 
-~ 
of hyperglycemia may also be a significant problem of 
'1 
the preterm neonate (Cornblath & Schwartz, 1976; 
Cowett et al., 1979; Miranda & Dweck, 1977; Zarif, 
Pildes & Vidyasagar, 1976). Originally, neonatal 
hyperglycemia was recognized as transient neonatal 
diabetes mellitus (Gentz & Cornblath, 1969). The 
spontaneously reversible deficiency of insulin 
secretion or the production of a biologically inactive 
form of insulin remains the hallmark of this disease 
(Cornblath, 1977; Gentz & Cornblath, 1969). This 
abnormal insulin secretion is suggestive of a delayed 
or abnormal maturation of pancreatic beta-cells and/or 
absence of inhibitors of pancreatic alpha cells in 
response to glucose infusion (Sodoyez-Goffaux & 
Sodoyez, 1977). Studies have documented neonatal hyper-
glycemic episodes in association with exogenous glucose 
infusions (Heird, Driscoll, Schullinger, Grebin & 
Winters, 1972; Zarif et al., 1976). This glucose 
intolerance is more prominent in the small-for-
gestational-age (SGA) infant (Dweck & Cassady, 1974). 
The reported hyperglycemia of the SGA infant following 
parenteral infusion of glucose is more likely to occur 
in the first 24-48 hours of life (Cowett et al., 1979; 
Dweck & Cassidy, 1974; Zarif et al., 1976) and is 
significantly more common at intravenous infusion 
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rates exceeding six mg/kg/minute (Cowett et al., 1979; 
Dweck & Cassady, 1974). 
The adult response to a small intravenous glucose 
infusion is a slightly elevated plasma insulin level 
with a decrease in glucose production and an increase 
in peripheral glucose uptake (Sacca, Vitale, Cicala, 
Trimarco & Ungaro, 1981). In comparison to their 
adult counterparts, the preterm infant may not have 
these abilities to respond to a glucose load. The 
! 
small preterm infant seems to be less able to turn off 
endogenous glucose production when exogenous glucose 
sources are provided (Sherwood & Chance, 1977). The 
preterm infant has the capacity to secrete insulin 
(Baum & Porte, 1980; Cowett et al., 1979; Salle & 
Ruitton-Uglienco, 1976). In fact, documentation of a 
brisk surge of insulin release can be stimulated by 
the infusion of intravenous amino acids (Fisher, 1975). 
Following a glucose infusion, a similar response of 
serum hyperinsulinemia can be obtained; however, serum 
glucose levels do not return toward normal values in 
response to this increase in insulin (Pollak et al., 
1978; Zarif et al., 1976). Some suggest that the 
insulin rise is inappropriately low in comparison to 
the degree of hyperglycemia observed. Immature 
function of the pancreas, causing a slower response 
of the beta-cells has been postulated to cause this 
discrepancy in serum insulin and glucose levels 
l~ 
(Zarif et al., 1976). This is supported by the fact 
that administration of supplemental insulin will 
facilitate a decrease in serum glucose values (Pollak 
et al., 1978). The inappropriate response to insulin 
may also reflect an ineffective delivery of insulin to 
the periphery or a decrease in sensitivity of peri-
pheral tissues to insulin. Reports of peripheral 
plasma insulin responses are extremely variable and 
seem to show no correlation to plasma glucose levels 
(Pollak et al., 1978). This fine control of glucose 
homeostasis in the pre term infant may require a higher 
insulin level to effectively lower endogenous hepatic 
output and/or enhance glucose utilization. Cowett 
and colleagues (1979) reported the responsiveness of 
end organ sensitivity to insulin may be the problem 
involved with glucose intolerance. A smaller mass of 
insulin-sensitive tissue (adipose tissue) of the 
very immature infant supports this thought (Pollak 
et al., 1978). It has also been hypothesized that 
the decreased response to insulin may be a result of 
an immature enzyme system (Goldman & Hirata, 1980). 
Growth hormone has varying effects on the neonate's 
response to plasma glucose and insulin levels. 
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Growth hormone stimulates protein synthesis and cell 
multiplication during periods of adequate nutrition 
(i.e., adequate calories, amino acids, and insulin 
levels). In fasting states, growth hormone levels 
increase while decreasing glucose uptake and stimulates 
fat mobilization, providing substrates for gluconeo-
genesis (Fletcher, 1981). Although the physiologic 
role of growth hormone in the human fetus is not 
clearly defined, it is not necessary for fetal growth 
(Adams, 1971). Several factors favor the conclusion 
that increased growth hormone levels during the first 
few days of neonatal life do not contribute to glucose 
intolerance: 
1. Neonatal serum growth hormone levels are 
elevated for the first few days of life 
(premature and full-term infants), regardless 
of serum glucose values or exogenous glucose 
supplementation (Fletcher, 1981; Zarif et al., 
1976) . 
2. There exists a paradoxical response of 
plasma growth hormone to an exogenous glucose 
load, showing a rise rather than a fall. 
This is a temporary pattern and disappears 
after the first few days of life (Adams, 
1971; Zarif et al., 1976). 
3. Growth hormone values among hyperglycemia 
and normoglycemic infants do not differ 
(Zarif et al., 1976). 
Stress has been identified as another significant 
factor responsible for hyperglycemia (Lilien, Rosenfield, 
Baccaro & Pildes, 1979; Rizza, Cryer, Haymond & Gerich, 
1980; Sherwood & Chance, 1977; Zarif et al., 1976}. 
Stress leads to excessive adrenergic activity resulting 
in increased circulating cortisol and/or catechola-
mine secretion. It has been reported that among 
premature infants with respiratory distress syndrome, 
those less than or equal to 32 weeks gestation had 
higher concentrations of corticosteroids than those 
greater than 32 weeks (Baden, Bauer, Colle, Klein, 
Papageorgiou & Stern, 1973). This would suggest an 
exaggerated response to stress or an attenuated 
ability to metabolize these hormones. Catecholamine 
levels in the stressed term and pre term infant demon-
strate an intact sympathetic-adrenal system. Catecho-
lamines (epinephrine and norepinephrine) rapidly 
mobilize glycogen stores through glycogenolysis, 
stimulate gluconeogenic substrates in the skeletal 
muscle and adipose tissue, decrease glucose clearance, 
and suppress pancreatic insulin output while augmenting 
glucagon secretion (Guyton, 1977). 
Stress hyperglycemia can result from a variety of 
predisposing conditions. Baum and Porte {1980} 
proposed that a series of interrelated events, trig-
gered by an acute hypoxemic episode and mediated by 
the sympathetic nervous system, stimulate adrenergic 
receptors and resulting in hyperglycemia (Figure 2). 
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Figure 2. A proposed mechanism for stress 
hyperglycemia. 
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A fall in arterial oxygen tension to levels less than 
30 torr, stimulates the alpha and beta adrenergic 
receptors. Alpha adrenergic stimulation is critical 
to hepatic glycogenolysis and is a major contributor 
22 
to the inhibition of insulin release in acute hypoxemia. 
In this study, hypoxia was also shown to cause a beta 
receptor dysfunction, resulting in alpha receptor 
domination, further promoting glucagon and inhibiting 
insulin release. Glucose clearance is also decreased 
due to the elevated circulating levels of catechola-
mines stimulated by the stress of the hypoxemia. The 
combination of these events result in hyperglycemia. 
Hyperglycemia has been reported in association 
with various shock syndromes (Cerchio, Persico & 
Jaffay, 1973; Cryer, Herman & Sode, 1971; James, 1979). 
Inadequate insulin response during an acute hypovolemic 
episode (Figure 2) was postulated as the major contri-
buting factor of hyperglycemia by James (1979). The 
inhibitory effects of catecholamines on pancreatic 
beta cells, resulting in inadequate insulin release, 
promotes glucose production and suppresses glucose 
clearance (Cerchio et al., 1973; Grajwer, Sperling, 
Sack & Fisher, 1977; Rizza et al., 1980). This 
response was reported as being primarily a beta 
adrenergic mechanism, whereas in hypoxemia, alpha 
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adrenergic responses predominate (Baum & Porte, 1980; 
Rizza et al., 1980). These apparently paradoxical 
findings suggest that the adrenergic mechanisms depend 
upon the specific nature of the stress-provoking 
condition (Johnson & Ensinck, 1976). 
The three anti-insulin hormones, glucagon, 
cortisol and epinephrine, when considered individually, 
result in a transient and often mild increase of the 
blood glucose concentration (DeFonzo, Sherwin & Felig, 
1980; Shamoon, Hendler & Sherwin, 1981). These 
studies suggest that stress hyperglycemia cannot be 
ascribed to a single hormone, but is a consequence of 
the synergistic interactions among these counter-
regulatory hormones. Glucose overproduction is stimu-
lated by glucagon and epinephrine, and sustained by 
elevated cortisol levels (Shamoon et al., 1981). 
Insulin levels in the normal subjects of this study 
demonstrated an increase over baseline, but not in 
direct correlation with the degree of hyperglycemia. 
This study suggests that a preexisting abnormality in 
insulin secretion is not required for the stress hyper-
glycemia potentiated by the three anti-insulin 
hormones (DeFonzo et al., 1980; Shamoon et al., 1981). 
Many believe that the dangers of hyperglycemia 
in the preterm neonate relate to changes in serum 
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osmolality (Dweck, 1976; Finberg, 1967). Each 18 
mg/dl increase in blood glucose concentration results 
in a 1 MOsm/liter increase in serum osmolality. The 
hyperosmolality caused by an increase of greater than 
25-40 mOsm/liter (>250 to 400 mg glucose/IOO ml blood) 
can result in a number of potentially deleterious 
consequences. The hazards of a sustained state of 
hyperosmolality may produce brain cell dysfunction, 
osmotic diuresis with subsequent dehydration, and 
expansion of vascular volume with capillary dilatation 
possibly contributing to a periventricular-intraventri-
cular hemorrhage (Arant & Gooch, 1979; Dweck, 1976; 
Dweck & Cassady, 1974; Finberg, 1967). The maximum 
safe tolerance in serum osmolality increase is suggested 
to be approximately 25 mOsm per liter of water (250 
mg/IOO ml) over four hours (Finberg, 1967). However, 
if sustained, even this degree of rise may result in 
any of the above complications (Dweck & Cassady, 1974; 
Zarif et al., 1976). 
Periventricular-Intraventricular 
Hemorrhage 
Peri ventricular-intraventricular hemorrhages have 
been reported to originate from the subependymal 
germinal matrix (Hambleton & Wigglesworth, 1976; 
Volpe, 1981). This region consists of the ventricular 
and subventricular zones found in every level of the 
developing central nervous system, from which all 
neurons and supporting glia originate. 
The germinal matrix of those infants up to 32 
weeks gestation is described as a capillary bed 
consisting of a network of interlacing blood vessels 
{Hambleton & Wigglesworth, 1976}. Heubner's artery, 
a branch of the anterior cerebral artery as well as 
the lateral striate and the anterior choroidal artery 
provide the major blood supply to the germinal matrix-
basal ganglia area. The relative large size of these 
vessels supports a substantial portion of cerebral 
blood flow during the critical period of neuronal 
proliferation {Hambleton & Wigglesworth, 1976; 
Takashima & Tanaka, 1978; Volpe, 1981}. 
The venous drainage system is provided through 
the terminal, choroidal and thalamostriate veins 
which course anteriorly and converge near the foramen 
of Monro and the head of the caudate nucleus forming 
the internal cerebral vein. The direction of flow 
takes a sudden u-turn at this point and the internal 
cerebral vein then courses posteriorly to eventually 
terminate in the Great Vein of Galen {Friede, 1975; 
Takashima & Tanaka, 1978; Volpe, 1981; Wigglesworth 
& Pape, 1980}. The sharp angle at this junction has 
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been suggested to be a particularly vulnerable zone 
for hemorrhage into the germinal matrix (Larroche, 
1964) . 
Previous studies in search of the origin of 
hemorrhage centered around the arteries and veins of 
the germinal matrix systems, primarily the terminal 
vein (Grontoft, 1953). Recent studies show a disruption 
of the microcirculation of the immature capillary bed 
as the origin of PV-IVH, rather than rupture of the 
terminal vein or its branches (Hambleton & Wigglesworth, 
1976). Although subependymal hemorrhages can occur -
wherever there is germinal matrix, there are recogniz-
able relationships to gestational age and site of 
rupture within the matrix. Hemorrhages of the very 
immature infant (less than or equal to 28 weeks 
gestation) were primarily over the body of the caudate 
nucleus, lateral to the body of the thalamus. The 
origin of PV-IVH in neonates 28-30 weeks gestation was 
predominantly over the head of the caudate nucleus 
adjacent to the foramen of Monro (Hambleton & 
Wigglesworth, 1976; Leech & Kohnen, 1974). The 
choroid plexus appeared to be the site of original 
rupture in infants greater than 30 weeks gestation 
(Donat, Okazaki, Kleinberg & Reagan, 1978). 
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Pathogenesis 
Various mechanisms have been attributed to the 
etiology of PV-IVH in the sick preterm infant. The 
structural and histological immaturity and characteristic 
vascular architecture of the large subependymal-germinal 
matrix are factors predisposing the preterm infant to 
a peri ventricular-intraventricular hemorrhage (Gruenwald, 
1951; Hambleton & Wigglesworth, 1976; Towbin, 1968; 
Wigglesworth & Pape, 1980). Cells migrate from the 
subependymal germinal matrix outward to form the layers 
of the cerebral cortex and deeper nuclear structures 
(Friede, 1975). The germinal matrix only begins to 
thin out at about 30 weeks gestation (Friede, 1975). 
This gelatinous matrix provides poor support for the 
capillaries and veins of this area thereby increasing 
their susceptibility to mechanical forces generated by 
intravascular pressure changes (Cole, Durbin, Olaffson, 
Reynolds, Rivers & Smith, 1974; Cooke, Rolfe & Howat, 
1979; Ross & Dimmette, 1965; Dykes, Lazzara, Ahmann, 
Blumenstein, Schwartz & Brann, 1980; Volpe, 1981; 
Wigglesworth & Pape, 1980). Pressure changes impli-
cated in the pathogenesis of PV-IVH include increase 
in central venous pressure (Cole et al., 1974; Dykes 
et al., 1980; Leech & Kohnen, 1974; Ross & Dimmette, 
1965), increase in mean arterial blood pressure 
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(Cooke et al., 1979; Ment, Ehrenkranz, Lange, Rothstein 
& Duncan, 1981; Wigglesworth & Pape, 1980), and/or 
alterations in the autoregulatory mechanisms of 
cerebral blood flow (Dykes et al., 1980; Lou, Lassen 
& Friis-Hansen, 1977; Ment et al., 1981). 
Asphyxia is the primary cause of increased venous 
pressure because it creates severe venous congestion 
and thrombus formation. This results in focal infarc-
tions in the subependymal area and eventual rupture of 
the thin-walled vessels of the germinal matrix 
(Grontoft, 1953; Gruenwald, 1951; Larroche, 1964; 
Leech & Kohnen, 1974; Ross & Dimmette, 1965; Towbin, 
1968). Hypoxic myocardial insufficiency secondary to 
asphyxia associated with respiratory distress of the 
premature contributes to this vascular disturbance 
(Cole et al., 1974). 
Under normal conditions, changes in cerebral 
vascular tone maintain cerebral blood flow within a 
constant narrow range regardless of wide variations 
in arterial blood pressure (Lou et al., 1977; Raju, 
Doshi & Vidyasagar, 1982). However, in the distressed 
newborn, a faulty autoregulatory mechanism results in 
a "pressure-passive" form of cerebral perfusion 
(Fujimura et al., 1979; Lou et al., 1977; Ment et al., 
1981). Impaired vascular autoregulation results in 
maximal cerebral vasodilatation (Lou et al., 1979). 
Volume expansion and/or sudden. rises in mean arterial 
blood pressure following periods of relative hypo-
tension can result in "luxury perfusion" to the sub-
ependymal germinal matrix area (Fujimura et al., 1979). 
Recent anatomic data indicating the capillaries as the 
origin of PV-IVH, support the notion that as arterial 
pressure rises, capillaries in the poorly supported 
germinal matrix may rupture (Cooke et al., 1979; 
Hambleton & Wigglesworth, 1976; Lou et al., 1979). 
The hypotension resulting in decreased cerebral 
perfusion could also lead to infarction of the germinal 
matrix capillary bed. Any subsequent increase in 
cerebral blood flow or increase in intravascular 
pressure could rupture the damaged microvasculature 
and lead to hemorrhage (Dykes et al., 1980). 
Others have also proposed a hypothesis of lowered 
cerebral tissue pressure as a factor leading to PV-IVH. 
The intravascular pressure acting on the vessel wall 
and the tissue pressure existing outside the vessel 
are the primary forces involved. If this transmural 
pressure gradient from the intravascular to extra-
vascular space becomes excessive, hemorrhage can 
result (Milnor, 1980). This excessive pressure 
gradient can occur with an increase in intravascular 
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pressure, a decrease in tissue pressure or a combination 
of both acting together. Although most studies reflect 
the view that either an increase in arterial or 
venous pressure is a major factor in PV-IVH (Cole 
et al., 1974; Connor, Lorenzo, Welch & Dorval, 1983; 
Grontoft, 1953; Hambleton & Wigglesworth, 1976; Ross 
& Dimmette, 1965; Wigglesworth & Pape, 1980), a 
reduced tissue pressure can also contribute signifi-
cantly to the development of hemorrhage (Coulter, 1980; 
de Courten & Rabinowicz, 1981). 
Tissue pressure varies directly with water 
content. Therefore, any condition which will decrease 
brain tissue water results in lowered cerebral tissue 
pressure. Plasma hyperosmolality resulting from 
dehydration, hypernatremia, hyperglycemia or infusion 
of hypertonic solutions will result in this type of 
water movement (de Courten & Rabinowicz, 1981; Papile, 
Burstein, Burstein, Koffler & Koops, 1979; Thomas, 
1981). Any situation which will decrease vascular 
filtration pressure (i.e., hypovolemia, hypotension) 
will also reduce water movement into the tissues 
(Connor et al., 1983; Milnor, 1980). A sudden 
increase in blood pressure in the face of lowered 
tissue pressure, particularly in the gelatinous, poorly 
supported matrix area, may readily result in rupture 
and hemorrhage (Goldstein, 1979; Lou et al., 1977). 
Water volume loss in the pre term infant brain 
tissue during the first 24-48 hours of life has been 
reported (Williams, Chir, Hirsch, Corbet & Rudolf, 
1977). This brain shrinkage was inferred because of 
a direct correlation between decreased head circum-
ference, loss of body weight and decreased serum 
sodium levels. Supporting this observation, Welch 
(1980) reported a gradual decline in intracranial 
pressure during this same time period in a comparable 
population of infants. However, an alternative 
explanation for smaller head measurements may be a 
decrease in cerebrospinal fluid volume. Another 
study directly assessing brain tissue hydration 
reported a direct correlation of brain water content 
to weight gain at 72 hours of age (Coulter & Avery, 
1980). Brain tissue from subjects gaining less than 
30% of their birthweight contained less water than 
those gaining greater than 30% of their birthweight. 
Thomas (1976) demonstrated a direct relationship 
between hyperosmolality and the occurrence of PV-IVH. 
Although there was no significant correlation between 
serum sodium levels and serum osmolality values, 
infants who died with PV-IVH demonstrated, at some 




two standard deviations above the mean compared to 
those without a PV-IVH (Thomas, 1976). In humans, 
approximately half of the plasma osmolality is due to 
sodium ions (Walker & Whelton, 1980). Therefore, a 
rise in serum sodium concentration would understandably 
lead to an increase in serum osmolality values. This, 
however, is not the case with neonates. Increased 
,serum osmolality values were associated with very low 
sodium concentrations. This finding would suggest the 
possibility of other molecules capable of increasing 
serum osmolality exerting an effect. Erdem, Gogus, 
Tuncer and Demisoy (1979) suggest that hyperglycemia 
may contribute to the hyperosmolality which may 
potentially lead to an intraventricular hemorrhage. 
Because the relationship between the variables hyper-
glycemia and PV-IVH seem to be related but have not 
been specifically investigated, it was this researcher's 
intent to explore this relationship further. To 
establish a correlation between the development of 
hyperglycemia and the occurrence of PV-IVH could 
potentially guide future investigations. 
Clinical Features 
Prior to the age of computerized tomography (CT) 
and ultrasound scanning, most PV-IVH were discovered 
on necropsy (Cooke, 1981; Kaplan, Ben-Ora, Hart & 
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Meyer, 1981). Employing these advanced techniques 
for in vivo observation of the cerebral structures has 
identified many cases of PV-IVH which would previously 
have gone unrecognized. Various associated risk 
factors have been identified as predisposing an infant 
to hemorrhage such as prematurity, gestational age, 
birthweight, Apgar score, sex, and respiratory 
distress (de Courten & Rabinowicz, 1981; Levene et al., 
1982; Schoenberg et al., 1977). Recently the effects 
of sodium bicarbonate infusion, mechanical ventilation, 
pneumothoraces and neonatal fluid balance have been 
named as factors associated with PV-IVH in these 
preterm infants (Goldstein, 1979: Hill, Perlman & 
Volpe, 1982; Levene et al., 1982; Thomas, 1976). 
Clinically, symptoms associated with a sudden 
deterioration in the cardiopulmonary status of an 
infant, (e.g., rapid deterioration, seizures, coma, 
as well as a more subtle presentation, e.g., altered 
state of consciousness, subtle aberrations in eye 
movement, gradual disturbances in respiratory function), 
lead to suspicion of a recent PV-IVH. Whether 
catastrophic or subtle, the presence of the above 
symptoms in conjunction with an unexplained drop in 
hematocrit, an inability to raise the hematocrit with 
a blood transfusion and/or a tight, bulging fontanel 
(Lazzara et al., 1980) should lead to questions and 
investigation of a possible PV-IVH. 
Diagnosis and Management 
Accurate diagnosis of PV-IVH has become an 
increasingly greater concern as neonatal care of 
preterm infants has improved. The need for a portable 
and noninvasive means for the detection and management 
of PV-IVH has been investigated. Real-time ultrasound 
provides a practical and efficient means of monitoring 
this intracranial lesion. Comparative studies of CT 
and ultrasound methods of detecting PV-IVH have shown 
excellent correlation in anatomic location, extent of 
hemorrhage, and the degree of ventricular dilatation 
(Kaplan et al., 1981; Sauerbrei, Digney, Harrison & 
Cooperberg, 1981). Ultrasonic imaging has facilitated 
monitoring and management of PV-IVH as well as 
furthering knowledge in the etiology of this lesion. 
The ultimate in management of PV-IVH would be 
the prevention of these lesions. However, until the 
delivery of preterm infants can be eliminated and/or 
the etiology of PV-IVH and its prevention can be 
determined, health care personnel are faced with both 
acute and longterm supportive care planning. Acute 
management includes supporting cardiopulmonary and 
metabolic status, the maintenance of cerebral perfusion 
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and avoidance of cerebral overperfusion (Volpe, 1981). 
Careful follow-up and monitoring for posthemorrhagic 
sequelae can be achieved rapidly and efficiently 
with the use of ultrasound. The most common long-term 
neurologic problems encountered after a PV-IVH are 
hydrocephalus, parenchymal damage and development 
of porencephaly (Kaplan et al., 1981; Volpe, 1981). 
Studies have revealed that the quantity of bleeding may 
have prognostic value in regards to the development of 
posthemorrhagic hydrocephalus (Ahmann et al., 1980; 
Papile, Burstein, Burstein, Koffler, Koops & Johnson, 
1980). Recent studies, based on both neurologic 
examination and developmental testing, report the 
incidence of abnormal outcome related to extreme 
prematurity (less than or equal to 27 weeks gestation) 
as well as severity of the initial hemorrhage (William-
son, Desmond, Wilson, Andrew & Garcia-Prats, 1982). 
Hydrocephalus exists when there is an imbalance 
between cerebral spinal fluid (CSF) production and 
absorption. In PV-IVH, hydrocephalus is primarily due 
to abnormal absorption resulting from obstruction of 
the outflow tract and from impairment of the reabsorp-
tive surface secondary to arachnoiditis. Obstruction 
is dependent upon pressure and tissue compliance 
(Ahmann et al., 1980). Both of these factors are 
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influenced by the developmental state of the preterm 
infant's intracranial structures which allow compres-
sion of cerebral white matter at pressures lower than 
those needed to overcome the restrictions of the dura 
and skull (Volpe, 1981). Papile et al., (1980) 
reported success with serial lumbar punctures to 
arrest progressive ventricular dilatation, lower CSF 
pressure and facilitate CSF absorption by removing 
blood and protein. Other researchers report that, 
in most cases, spontaneous resolution of ventricular 
dilation is observed even without intervention 
(Levene & Starte, 1981). 
Cerebral compression resulting in brain injury 
due to progressive ventricular dilatation may occur 
days to weeks before the appearance of traditional 
clinical features of splitting cranial sutures, 
bulging anterior fontanelle and rapidly increasing head 
growth (Volpe, Pasternak & Allen, 1977). This delay 
in detection and treatment may be an important 
determinant in the poor neurological outlook in PV-IVH 
(Papile et al., 1980; Volpe et al., 1977). Early inter-
vention to lessen brain injury (i.e., axonal swelling 
and disruption) is now possibly due to CT and ultra-
sound scanning techniques. Clinical features helpful 
in prognosticating the outcome from PV-IVH could also 
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guide the management and follow-up from this hemorrhagic 
event. Merguerian, Perel, Wald, Feinsod, and Coter 
(1981) reported that persistent hyperglycemia was a 
grave prognostic sign in adult head-injured patients. 
This study will also investigate hyperglycemia in the 
preterm infant in relation to the existence and extent 
of a periventricular-intraventricular hemorrhage. 
were: 
Research Questions 
The research questions addressed in this study 
1. Does hyperglycemia occur in relation to 
the onset of clinical signs of PV-IVH? 
2. Is the degree of glucose intolerance 
reflective of the grade of PV-IVH? 
3. Is the degree of hyperglycemia, regardless 
of the grade of the PV-IVH, related to 
the development of posthemorrhagic 
hydrocephalus? 
Definition of Terms 
1. Periventricular-intraventricular hemorrhage 
(PV-IVH) was defined as hemorrhage into 
the region of the terminal vein of the 
subependymal germinal matrix. This 
lesion is graded by severity (Papile et al., 
1978) as follows: 
a. Grade I-a subependymal hemorrhage 
b. Grade II-an intraventricular hemorrhage, 
without ventricular dilatation 
c. Grade III-an intraventricular hemorrhage 
with ventricular dilatation 
d. Grade IV-an intraventricular hemorrhage 
with ventricular dilation plus paren-
chymal extension of the hemorrhage. 
2. A premature infant was considered neonate 
born at less than or equal to 37 weeks 
gestation. 
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3. Gestational age was defined as the post-
conceptual age of a fetus/neonate and was 
determined by admission physical examination. 
4. Posthemorrhagic ventricular dilatation was 
considered as ultrasonographic diagnosis of 
enlarged ventricles following a PV-IVH. 
5. A posthemorrhagic hydrocephalus was defined 
as a progressive enlargement of the 
ventricles with abnormal head growth, requiring 
surgical placement of a ventriculo-peritoneal 
shunt. 
6. Hyperglycemia was defined as a serum glucose 
value greater than or equal to 120 mg/dl. 
a. Hypoglycemia = < 39 mg/dl 
b. Euglycemia = 40-120 mg/dl 
c. Mild hyperglycemia = 121-169 mq/dl 
d. Moderate hyperglycemia = 170-210 mg/dl 
e. Severe hyperglycemia 211-249 mg/dl 
f. Very severe hyperglycemia = ~ 250 mg/dl. 
7. Ventilatory support was defined as infants 
requiring endotracheal intubation and 
attachment to a mechanical ventilator. 
a. Hinimum support = CPAP and/or Ir·1V L 
10 and/or pressures 18/3 
b. Mild support = IMV L 20 and/or pressures 
!:= 25/5 
c. Moderate support = II,1V L 30 and/or 
pressures ~ 30/5 
d. Maximum support = IMV ~ 31 and/or 
pressures 31/6. 
8. Stress was considered a disturbance in the 
component(s) of a system resulting in a 
dysfunction or disorganization of the system. 
Assumptions 
The assumptions in this research study were: 
1. A disturbance or stress has been imposed on 
the system which is reflected in hyper-
glycemia. 
2. Hyperglycemia causes additional stress on a 
system. 
3. PV-IVH is preceded by a system disturbance. 
4. The clinical signs potentially associated 
with PV-IVH can be determined from the 
examination of the progress notes and/or 




The design of this study was an ex post facto, 
descriptive correlational investigation. Ex post 
facto research allows the investigator to systemati-
cally examine relationships among variables (Polit 
& Hungler, 1978; Waltz & Bausell, 1981). This design 
is often utilized in research studies involving human 
beings for the following reasons: 
1. The complexity of interacting variables 
involved in maintaining homeostasis among 
the various subsystems of the human body. 
2. The nature of the independent variable 
involved is such that its manipulation 
could potentially cause physical harm to 
the subject. 
3. Constraining situations (i.e., insufficient 
time, inconvenience, lack of cooperation, 
and/or lack of adequate funds) may make a 
true experiment nonpractical (Polit & 
Hungler, 1978). 
A content analysis of patient medical records was 
performed to investigate the independent variable of 
hyperglycemia as a factor involved with periventricular-
intraventricular hemorrhages of the preterm infant. 
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Retrospective studies cannot infer a causal relation-
ship. However, the identification of a correlation 
between the independent variable and the dependent 
variable under study could direct further research. 
The time series analysis (Campbell & Stanley, 
1963) is an ex post facto design in which there is a 
periodic measurement (Dextrostix~ determinations) on a 
group and the introduction of an experimental change 
or the occurrence of a natural event (PV-IVH) into 
this time series of measurements (Campbell & Stanley, 
1963). The (dis)continuity in the recorded DextrostixQY 
measurements (Ol-Oa) in the time series before and 
after the PV-IVH (X) will be compared in an attempt 
to identify the effect of X (Figure 3). 
Threats to internal validity which may offer 
alternative explanations for the (dis) continuity of 
the serial measurements need to be addressed. Failure 
to control for history is a weakness of this design 
(Campbell & Stanley, 1963). A simultaneously occurring 
event, other than X, may result in these discontinuous 
measurements as well. Awareness of rival events known 
to cause hyperglycemia and exclusion of subjects 
affected by these events from the study lends greater 
credence to the interpretation of obtained data. 
Instrumentation is another possible confounding 





o * 8 
post-PV-IVH Dextrosti~ 
42 
Figure 3. Research design. (*Notation developed 
by Campbell & Stanley, 1963). 
variable associated with this design (Campbell & 
Stanley, 1963). Inaccurate usage of the various 
instruments utilized in determining: 1) Dextrostix~ 
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reading and 2) PV-IVH grading, could be misinterpreted 
as being the effect of X. This factor is even more 
prevalent in an ex post facto chart analysis. Know-
ledge of skill, technique and experience of individuals 
f 'h '~d' d th It d per ormlng t e Dextrostl  rea lngs an e u rasoun 
imaging is not readily accessible. 
Another weakness of this study design was the 
inability to randomize and the inability to manipulate 
the independent variable. This lack of control results 
in an increased risk of over interpretation of the 
results (Kerlinger, 1973). 
Despite its weaknesses, ex post facto correlational 
studies are advantageous in many research situations in 
which a controlled inquiry is desired but true experi-
mentation is not feasible (Kerlinger, 1973). The design 
described above can result in an efficient and effective 
means of investigating a problem area in which the 
variables involved are very complex and involves the 
collection of a large amount of data (Kerlinger, 1973: 
Polit & Hungler, 1978: Waltz & Bausell, 1981). Cor-
relational studies are very strong in realism. The 
results of a study obtained in a natural setting are 
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more likely to be generalizable to other similar settings 
than results obtained in an experimental laboratory 
setting (Kerlinger, 1973; Polit & Hungler, 1978). 
Several studies have examined the various 
clinical features often associated with PV-IVH 
(Lazzara et al., 1980; Lilien et al., 1979). Hyper-
glycemia and PV-IVH in these reports were not found to 
be significantly correlated. No study investigating 
the specific variable of hyperglycemia in relation to 
PV-IVH was discovered in this investigator's review 
of the literature. However, Erdem et al., (1979) 
reported one case study and others have speculated 
how hyperglycemia may predispose preterm infants to 
this neurologic complication (Arant & Gooch, 1979; 
Dweck, 1976; Dweck & Cassady, 1974; Finberg, 1967). 
A retrospective correlational study using content 
analysis of medical records seems to be an appropriate 
preliminary research step in identifying the existence 
of a relationship between the variables in question. 
A causal relationship cannot be determined by this 
type of study. 
Instruments 
Dextrostix 
The Dextrostix~, a Miles Laboratory product, is 
a firm plastic strip which has an area of reagents 
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employed to determine the amount of glucose in whole 
blood. The active end of the test strip is impregnated 
with a glucose-oxidase/peroxidase chromagen mixture 
and coated with a semipermeable membrane which prevents 
staining by red blood cells. Glucose from the blood 
passes through this membrane and initiates the dry-
reagent system of glucose oxidation producing character-
istic colors of the oxidized chromagens. The intensity 
of the color is proportional to the glucose concen-
tration in the blood (Miles Laboratory, 1979-80; Moss, 
1968; Rennie, Keen & Southon, 1964). 
This semiquantitative enzyme-strip method for 
estimating blood glucose values was first introduced 
in 1964 (Moss, 1968; Orzeck, Mooney & Owens, 1971; 
Rennie et al., 1964), and is found an efficient and 
effective screening tool, when performed by experienced 
laboratory technologists (Perelman, Gutcher, Engle & 
MacDonald, 1982). In one minute, this method 
requiring one drop of blood, provides a visual range 
of blood glucose levels between zero and 250 mg glucose/ 
dl (Miles Laboratory, 1979; Moss, 1968; Orzeck et al., 
1971). However, limitations of this glucose screening 
method have been identified as follows: 
1. Operator variables such as timing, washing 
and sample application must closely follow 
directions supplied by Miles Laboratory (1979), 






1968; Rennie et al., 1964). 
Reagent strip deterioration may result from 
exposure to light, heat and ambient- moisture 
as well as aging of the Dextrosti~ resultinq 
in inaccurate values (Miles Laboratory, 1979-80). 
Observer inexperience in strip/color-chart 
interpretation may introduce error into the 
results (Miles Laboratory, 1979-80; Rennie et 
al., 1964). 
A number of potentially interfering substances 
have been identified, such as an elevate~ 
hematocrit resulting in a low Dextrosti~ 
reading (Strauchen, Alston, Anderson, 
Gustafson & Fajardo, 1981), isopropyl algohol 
resulting in erroneously high Dextrosti~ 
values (Grazaitis & Sexson, 1980), and the 
chemical, fluoride, interfering with reagent 
strip reaction (Miles Laboratory, 1979-80). 
Dextrostix~ under-and-overestimations have 
been noted at extremely high and extremely 
low blood sugar levels respectively (Miles 
Laboratory, 1979-80; Perelman et al., 1982; 
Rennie et al., 1964). 
Dextrometer 
The dextrometer is a reflectance colorimeter 
which quantitatively measures the degree of color 
change on the Dextrosti~ reagent strip (Miles 
Laboratory, 1979 80). A microcomputer within this 
compact and portable instrument interprets the 
electrical signals reflected from the reagent area 
and digitally displays the resultant glucose value. 
The manufacturer provides simple calibration methods to 
continually assure reliable results. Data based upon 
a dextrometer calibrated with a 130 mg/dl solution 
shows an approximate 97% correlation between semi-
automated whole blood glucose determination and the 
dextrometer/Dextrosti~ system. This data further 
demonstrated that dextrometer readings were within 5% 
of the actual blood glucose concentration within the 
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range of 50-350 mg/dl glucose (Miles Laboratory, 1979-80). 
The dextrometer/Dextrostix~method of glucose 
screening is utilized by the University of Utah Medical 
Center's NICU. Dextrometer values less than 30 and 
greater than 130 mg/dl are followed up by chemical 
blood sugar estimations. 
Real Time Ultrasound 
Sector Scanner 
Ultrasonography is a method of producing two 
dimensional images of biologic soft tissues using high 
frequency sound energy_ The acoustic property of 
various bodily tissues is primarily determined by 
the presence of collagen and fat micelles within the 
tissues. Therefore, the image is essentially a map 
of the collagen and fat distribution of the tissue 
(Field & Dunn, 1973) _ Structures rich in collagen and 
fat are more echogenic, whereas liquids containing no 
collagen or fat are virtually devoid of echoes. The 
varying intensities of echoes are displayed as shades 
of gray. The University of Utah Medical Center 
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utilizes the Advanced Technology Labs Real Time ultra-
sound sector scanner. This system is suitable for 
grayscale imaging of cardiac, abdominal and peripheral 
vascular structures up to a depth of 30 cm (Advanced 
Technology Labs, 1980). 
Two dimensional ultrasound scanning has allowed 
in vivo visualization of PV-IVH (Cooke, 1981; Kaplan 
et al., 1981; Levene, Wigglesworth & Dubowitz, 1981). 
The ultrasound equipment is portable and does not 
require radiating the patients, thus making this 
method ideal for studying infants in the NICU. 
Sampling and Data Collection 
Procedures 
A nonprobability convenience sample of infants at 
the University of Utah Medical Center's Newborn ICU 
was utilized. Subjects were identified by a computer 
search. The sampling time period encompassed those 
years in which the diagnosis of PV-IVH was achieved 
through the use of ultrasonography. Infants to be 
included in this study will be: a) preterm (less than 
37 weeks gestation), b) hyperglycemic, and/or c) 
diagnosed with PV-IVH during the first seven days of 
life. Because glucose intolerance has been reported to 
be associated with infants diagnosed with sepsis and/or 
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necrotizing enterocolitis, these infants were excluded 
from the study (Cryer et al., 1971; Lanham, 1982). 
CHAPTER IV 
RESULTS AND DISCUSSION 
The statistical computation was performed by a 
Sperry Univac 1100 Computer located at the University 
of Utah Computer Center (Salt Lake City, Utah). The 
Statistical Package for the Social Sciences (SPSS) 
(Nie, Hull, Steinbrenner & Brent, 1975) program and 
the Stat 80 program were utilized for data analysis 
(Fullerton, 1981). The statistical level of confidence 
was established at a value of E,L 0.05. 
Descriptive Data 
Computerized data retrival identified a total of 
257 charts of preterm infants (less than or equal to 
37 weeks gestation) born between the months of 
December, 1981 and December, 1982. Of these 257 
charts, 102 subjects were identified as having the 
primary diagnosis of PV-IVH, PV-IVH and hyperglycemia 
(GH), or hyperglycemia (HG). Four charts were unavail-
able from the medical records department. Forty-one 
charts did not fit the criteria for the study due to 
confounding diagnosis of sepsis, necrotizing enteroco-
51 
litis and/or PV-IVH occurring after the first week of 
life. One infant experiencing hyperglycemia (HG) 
initially, then subsequently developing a PV-IVH at 
two weeks of life was only included in Group III 
(hyperglycemia only) . 
Data were collected from the remaining 57 charts 
and then subdivided into three groups of preterm 
infants as follows: 
1. Group I: PV-IVH only (~ = 6) 
2. Group II: PV-IVH with hyperglycemia (N = 33) 
3. Group III: Hyperglycemia only (~ = 18) 
The means, standard deviations and ranges performed 
for descriptive analysis of the demographic data are 
presented in Table 1. 
Males and females were equally represented in 
Groups II (PV-IVH/HG) and III (HG). In Group I (PV-IVH), 
four of the six infants were male, representing 67% of 
this sample. The small sample size of Group I makes 
this difference in demographic comparisons difficult 
to interpret; however, PV-IVH has been reported to 
occur more frequently in males than females (de Courten 
& Rabinowicz, 1981; Wigglesworth & Pape, 1980). Birth 
stress was evidenced by low Apgar scores at one 
(mean = 3.9) and five minutes (mean = 6.4). The mean 
one and five minute Apgar scores were higher for 
Table 1 
Group Comparisons of Demographic Data Means, Standard Deviations and Ranges 
Group I Group II Group III 
(N) = 6 (N) = 33 (~) = 18 Total 
Variable (PV-IVH) (PV- IVH/HG) (HG) (N) = 57 
X D. Range X S.D. Range X S.D. Range X S.D. Range 
--
Gestational Age 29 2.4 26-32 31 1.6 27-34 29 2.9 25-34 30 2.2 25-34 
(Weeks) 
Birth Weight 1115 277 670- 1326 340 790- 1191 529 680- 1261 405 670-
(Grams) 1410 1950 2200 2200 
Apgars: 
1 minute 2.2 1.2 1-4 4.7 2.1 1-8 3.1 2.2 1-8 3.9 2.2 1-8 
5 minutes 5.5 1.0 4-7 6.7 1.7 3-9 6.2 1.5 2-8 6.4 1.6 2-9 
Length of 
Hospitalization 34 21.7 8-56 36 22.3 1-93 31 22.9 1-81 34 22.1 1-93 
(Days) 
infants in Groups II and III from those in Group I. 
The average length of hospitalization was 34 days 
(S.D. 22.1). 
More than 80% of the infants in this study 
sample were born at the University of Utah Medical 
Center (Table 2). A greater percentage of infants 
from Group I were transported back to the referring 
hospital and fewer were sent directly home when 
compared to infants from Groups II and III. Ten of 
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57 infants died in this study with a slightly larger 
percentage of these infants occurring in Group III (22%). 
The demographic description of this study sample is 
similar to those reported in other studies (Dykes et 
al., 1980: Leech & Kohnen, 1974: Shinnar et al., 1982: 
Wigglesworth & Pape, 1980). 
Eighty-nine percent (51/57) of the infants in this 
study had hyperglycemia (Table 3). Lowering of 
exogenous glucose input (in 35 of 57 infants) was the 
primary method of treating the increase in serum 
glucose values. Five infants in Group III (28%) 
required the pharmacologic intervention of insulin 
compared to 9% (3/33) in Group II to combat the hyper-
glycemia. 
Examination of all hyperglycemic subjects revealed 
that 61% (33/51) of this sample had a PV-IVH. In 
Table 2 
Type of Admission and Discharge Disposition 
Comparison of Groups 
Group I Group II Group III 
(N) = 6 (N) = 33 (N) = IS 
variable (PV-IVH) (PV-IVH/HG) (HG) 
Total 
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Treatment of Hyperglycemia 
Comparison of Groups 
Group II Group III 
Variables (N) = 33 (~) = 18 Total ( PV- IVH/HG) (HG) (N) = 57 
(~) % (N) % (~) % 
Insulin 3 9% 5 28% 8 14% 
Low Exogenous 20 61% 15 83% 35 61% 
Glucose 
comparison, 85% (33/39) infants experiencing PV-IVH 
also demonstrated a hyperglycemic episode. 
5~ 
The overall icidence of PV-IVH in the 57 cases 
studied was 68% (39/57). This is somewhat greater 
than the 35-50% reported in the literature (Ahmann et 
al., 1980; Leech & Kohnen, 1974; Levene & Starte, 1981; 
Papile et al., 1981; Shinnar et al., 1982). 
Documentation of hemorrhage was by echoencephalo-
gram; however, other factors were also noted (Table 4). 
All PV-IVH episodes were documented at a mean of 4.8 
days of life (range 1 to 11 days). Although lumbar 
punctures were not routinely performed in infants 
suspected of having a PV-IVH, three infants in Group 
II (9%) had documentation of blood in the cerebral 
spinal fluid (CSF). A full fontanelle was observed in 
only six percent (2/33)! of the infants in Group II. 
The grading of the severity of PV-IVH followed 
the criteria described by Papile et al., (1978) as 
presented in Table 5. The mean age of ventricular-
peritoneal shunt placement was 43 days (range = 26-61 
days). The subject from Group III (described earlier 
as developing a PV-IVH after the study period), 
subsequently required shunt placement and accounts for 
the fifth infant in this study needing a shunt. 
Table 4 
Documenting Factors of a PV-IVH Group Comparison 
Group I Group II Total 
Variable (N) = 6 (!i) = 33 ( !i.) = 57 
X S:-D. Range X S.D. Range X S.D. Range 
Age of positive echoencephalogram 4.8 2.0 2-8 4.6 1.6 1-8 4.8 1.8 1-11 
(days) 
Age of bloody CSF by lumbar 3.0 2.0 1-5 3.2 1.5 1-5 
puncture (days) 
Age of fontanelle change (days) 3.5 0.7 3-4 3.0 1.4 1-4 
58 
Table 5 
Comparison of Severity of PV-IVH and the Need 
for Shunt Placement 
Group I Group II Total 
Grade (N) = 6 (N) = 33 (N) = 57 
(N) % (N) % (N) % 
I. 2 33% 14 42% 16 28% 
II. 4 12% 4 7% 
III. 3 50% 8 24% 11 19% 
IV. 1 17% 7 21% 8 14% 
No IVH 18 31% 
Shunt 1 17% 3 9% Sa 9% 
Note. a One infant from Group III. 
Research Question One 
Does hyperglycemia occur in relation 
to the onset of clinical signs of 
PV-IVH? 
Recovering information required to document the 
onset of PV-IVH from the medical records presented 
some difficulties. Symptoms associated with subtle 
59 
or catastrophic deterioration in conjunction with other 
signs of possible PV-IVH (Lazzara et al., 1980; Volpe, 
1981), were inconsistent. Possible explanations for 
this inconsistency include lack of accurate documen-
tation of clinical events or absence of these specific 
clinical symptoms (a silent PV-IVH). Therefore, the 
information gathered from the patient charts was 
examined only to identify if an association between 
the variables of PV-IVH and hyperglycemia are related. 
To test the association of hyperglycemia in 
relationship to the occurrence of PV-IVH, the Mantel-
Haenszel Chi-square (MHx2) analysis was applied. 
Descriptive statistics on Dextrosti~ values and PV-IVH 
determinations obtained from patient charts were also 
computed. Graphic illustrations of the range and 
mean distribution of Dextrosti~ values for the three 
groups of infants are presented in Figures 4-6. Figure 
4, depicting the Dextrostix~ trends for infants in 
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Figure 5. Dextrosti~readings (means and ranges) group II 
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Figure 6. Dextrosti~readingS (means and ranges) group III (HG) (!:! = 18). 
within the euglycemic range. Group II (PV-IVH/HG) 
(Figure 5) had wide ranges of Dextrostix~ values, 
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particularly between days two and six. Note the eight 
hour period on day two with the sudden and dramatic 
rise of Dextrostix@ readings well above the "very 
severe" glucose value of 250 mg/dl. This sudden rise 
in glucose level is again seen on days five and six. 
In Group III (HG) the glucose values consistently 
trend in the hyperglycemic range (Figure 6). The only 
sudden rise from baseline noted in this group is on 
day six. 
Stress indicators were evaluated during the time 
of DextrostixaY recordings. Group comparisons are 
presented in Table 6. Group I (PV-IVH) infants 
experienced no cardiorespiratory status deterioration 
during the first week of life. In Group II (PV-IVH/HG) 
and III (HG), a rise in the percentage of infants 
experiencing cardiorespiratory difficulties is noted 
on day three. Consistently larger percentages of 
infants in Groups II and III required moderate to 
maximum ventilatory support. No infant in Group I 
developed a pneumothorax whereas in Group II pneumo-
thoraces occurred daily until day five. Although all 
groups experienced hypothermia, Group II (PV-IVH/HG) 
had a larger percentage of hypothermic subjects. 
Table 6 
Group Comparisons of Percentages of Stress Experienced 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Stress Group Group Group Group Group Group Group 
Indicator I II III I II III I II III I II III I II III I II III I II IIJ 
Ventilatory Support 
Moderate 9% 33% 15% 17% 17% 27% 28% 15% 6% 3% 17% 3% 
Maximum 17% 39% 39% 33% 48% 44% 17% 33% 50% 18% 39% 6% 6% 3% 
Pneumothorax 6% 3% 3% 6% 6% 6% 3% 
Hypothermia 33% 46% 44% 27% 17% 17% 24% 17% 17% 15% 6% 15% 6% 17% 6% 6% 17% 6% 
Acidosis 18% 11% 17% 27% 22% 21% 28% 6% 22% 3% 6% 3% 
Cardiopulmonary 9% 17% 15% 11% 27% 33% 9% 17% 3% 6% 3% 3% 
Deterioration 
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Acidosis was encountered in larger percentage in Groups 
II and III primarily on days one through three. 
In summary, Group II (PV-IVH/HG) and III (HG) 
infants had larger percentages of infants experiencing 
stressful events, notably during the first three to 
four days of life. Dextrosti~values of these same 
groups show the widest ranges of values on days one 
through four. Sudden rises of Dextrostix~ values 
from baseline were seen primarily on days two through 
five. 
The Mantel-Haenszel Chi-square (MHX2) analysis 
demonstrated a significant correlation between the 
occurrence of hyperglycemia and PV-IVH on all seven 
days of the study period (Table 7). 
The cumulative data for the sample studied 
demonstrated a risk ratio of these two variables 
occurring together of 12.10 (E ~ .000001). 
The methodology of this study does not allow 
the establishment of a temporal relationship between 
the hyperglycemia and PV-Iv~. However, the significant 
risk of these two factors occurring together can be 
addressed. Animal studies have shown an increased 
survival time following anoxic stress with infusion 
of exogenous glucose (Holowack-Thurston, Hauhard & 
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anoxia was suggested to reflect an increase in cerebral 
anaerobic glycolysis which exceeded the increase in 
glucose transfer. However, the lower cerebral glucose 
values did not correspondingly result in lower plasma 
values. Pancreatic output of insulin is also found to 
be diminished with most forms of shock and circulatory 
failure (Baum & Porte, 1980; Cerchio et al., 1973; 
Shamoon et al., 1981). The stress (hypoxia, circulatory 
collapse, shock) occurring with PV-IVH could: 
1. lower perfusion to the pancreas resulting 
in diminished portal and peripheral 
insulin levels and/or 
2. result in endogenous catecholamine release 
inhibiting the pancreatic beta-cell function 
in producing insulin (Cerchio et al., 1973). 
The hypoinsulinemia leads to elevated serum glucose 
levels which can then be diverted to noninsulin 
dependent tissues (i.e., central nervous system) to 
meet the increased energy requirements experienced 
during acute shock states (Baum & Porte, 1980). 
This concept is further supported by studies 
demonstrating that the relatively low cerebral blood 
flow of the germinal matrix area (Ment et al., 1981; 
Pasternak, Groothus, Fischer & Fischer, 1982), 
selectively increases in the presence of PV-IVH 
without the corresponding increase in cerebral 
metabolic rate. Under these conditions (increased 
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cerebral blood flow without increased cerebral metabolic 
rate), animal studies demonstrate widespread alterations 
in local cerebral glucose utilization. In the adult 
rat, glucose uptake of the periventricular white matter 
increased while other brain regions decreased (Pulsinelli 
& Duffy, 1979). The resultant uniformity of cerebral 
glucose uptake differs from the normal heterogeneity of 
cerebral glucose utilization, thus providing a small 
amount of glucose substrate uniformly throughout the 
brain during a stressful event. 
The use of positive emission tomography has 
demonstrated not only the reduced cerebral blood flow 
to the area of hemorrhage intracerebral involvement, 
but also a marked reduction in blood flow throughout 
the affected hemisphere (Volpe, Herscovitch, Perlman 
& Raichle, 1983). With the sudden reduction in blood 
flow, one could surmise that cerebral glucose utili-
zation would also decline and result in an elevation 
in serum glucose levels. 
Further analysis of the data (MHX2) included 
investigation of the correlation of PV-IVH with the 
various stress indicators listed in Table 7. Require-
ment of maximum or moderate ventilatory support 
(E< .000001) and/or the occurrence of a pneumothorax 
(E< .00018) were the only factors significantly cor-
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related with the occurrence of PV-IVH (Table 8). 
A close temporal relationship of PV-IVH and 
pneumothorax has been reported (Dykes et al., 1980; 
Hill, Perlman & Volpe, 1982). The increased intra-
thoracic pressure experienced with pneumothorax leads 
to the cardiovascular hemodynamic changes which 
increase the flow to the anterior cerebral artery. 
This can potentiate and/or cause a PV-IVH in a predis-
posed infant. 
Reports of respiratory distress and the subsequent 
need for mechanical ventilatory assistance is signifi-
cantly related to the occurrence of PV-IVH (Cooke, 1981; 
Levene et al., 1982). Other risk factors such as 
hypercarbia and acidosis seemed to be related to the 
respiratory distress experienced by preterm infants. 
The increase in paC02 and the decrease in the blood 
pH has been postulated to result in cerebral vaso-
dilatation which is an etiologic factor in PV-IVH 
(Levene et al., 1982; Wigglesworth, Davies, Keith & 
Slade, 1977). In contrast, Bucciarelli and Eitzman 
(1979), demonstrated in goats the linear relationship 
of cerebral blood flow to hydrogen ion content being 
independent of paC02 values. Papile and colleagues 
(1978) reported an in vivo study in which these 
perinatal factors as well as the need for respiratory 
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Table 8 
Mante1-Haensze1 Chi-square Analysis of 
PV-IVH and Stress Indicators (~) = 57 
Stress Indicator Risk Ratio P-Va1ue 
Ventilatory Support 13.928 .000001 
Pneumothorax 15.395 .00018 
Hypothermia 1.099 .884 
Acidosis .804 .932 
Cardiorespiratory .517 .405 
Deterioration 
assistance was not related to the development of an 
intraventricular hemorrhage. In the present study, 
acidosis, hypothermia, and cardiorespiratory status 
deterioration did not demonstrate a significant risk 
for the development of a PV-IVH in this sample. The 
possible difficulty in identifying clinical features 
of a PV-IVH is acknowledged due to the wide variations 
of presentation. Only those infants demonstrating a 
catastrophic deterioration at the time of the PV-IVH 
were readily identified. Other cases experiencing 
more subtle deterioration or those clinically not 
evident may have been unidentifiable by the chart 
review. 
The MHx2 analysis was also employed to examine 
the correlation between the five stress indicators 
with the occurrence of hyperglycemia (Table 9). 
Cardiorespiratory status deterioration was the only 
variable significantly correlated (E< .05) with hyper-
glycemia. 
The statistical significance of cardiopulmonary 
deterioration with the occurrence of hyperglycemia 
has been reported by others, suggesting an adrenergic 
mechanism responding to the stress factors comprising 
this category (Baum & Porte, 1980). The weakly 
correlated stress indicator of ventilatory support 
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Table 9 
Mantel-Haenszel Chi-square Analysis of 
Hyperglycemia and the Stress 
Indicators (~= 57) 
Stress Indicator Risk Ratio P-Value 
Ventilatory Support 6.500 .084 
Pneumothorax 2.540 .674 
Hypothermia 2.923 .437 
Acidosis 5.625 .216 
Cardiorespiratory 14.592 .045 
Deterioration 
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(E = 0.084) to hyperglycemia may reflect the inter-
relatedness of. respiratory distress, hypoxemia, 
hypercarbia, and acidosis to the overall category of 
cardiopulmonary deterioration (Bucciarelli & Eitzman, 
1979; Levene et al., 1982; Wigglesworth et al., 1977). 
The stress responsible for the glucose intolerance 
may even be a result of massive intracranial hemorrhage 
(Cepeda, Heilbronner & Poland, 1978). 
The mortality rate among hyperglycemic infants 
has been reported to be more closely associated with 
the stress rather than the hyperglycemia involved 
(Lilien et al., 1979). Data from this study support 
this postulation. Group III (HG) had the largest 
percentage (22%) of the infants that died (Table 2). 
The mortality rate from groups I and II was 17% and 
15%, respectively. Group II's infants also experi-
enced a greater percentage of stressful events (Table 
7) • 
While exogenous glucose infusions have been 
reported to be higher in infants with glucose intol-
erance in the presence of PV-IVH (Cepeda et al., 1978), 
glucose infusions did not vary significantly among 
the three groups of infants in this study (Table 10). 
Research Question Two 


















reflective of the grade of the PV-IVH? 
Descriptive statistics, the Spearman rho cor-
relation coefficient and the Mann-Whitney U tests were 
used to analyze the association of the degree of 
glucose intolerance reflecting the grade of PV-IVH. 
The Dextrostix~ readings and the echoencephalogram 
interpretations, used to grade the PV-IVH (Table 5), 
were obtained from the medical records. 
Determination of Spearman's rho showed no 
significant correlation between the degree of hyper-
glycemia and the grade of PV-IVH. However, further 
analysis of the data by the Mann-Whitney U test 
revealed a significant relationship between the 
degree of hyperglycemia and just the occurrence of 
a PV-IVH (g = 161.5; E< 0.132). 
The increases in serum osmolality exceeding 
25-40 mOms/liter of water associated with intra-
cranial hemorrhage (Finberg, 1967) would require a 
serum glucose value of greater than 250-400 mg/100 ml 
of blood. Others have reported that an increased 
incidence of PV-IVH indeed, does occur when blood 
glucose values exceed the 400 mg/100 ml of blood 
(Zarif et al., 1976). The findings of this study 
sample are consistent with the above findings in 
that the degree of hyperglycemia is significantly 
associated with the occurrence of PV-IVH. However, 
it is not predictive of the severity of PV-IVH. 
In attempting to discuss the etiologic components 
that determine the extent of a PV-IVH, examination 
of multiple factors are necessary. The maturity of 
the infant influences the intravascular and extra-
vascular forces, cerebral metabolic rate, capillary 
integrity, the supporting capacity of the basement 
membrane and other pathogenetic risk factors of PV-IVH 
(Dykes et al., 1980; Gruenwald, 1951; Hambleton & 
Wigglesworth, 1976; Ment et al., 1981; Pasternak et al., 
1982; Volpe, 1981; Wigglesworth & Pape, 1980). 
Various endogenous and autoregulatory responses 
to the stress experienced by a small pretern infant 
influence the cerebral blood flow (Bada et al., 1982; 
Bucciarelli & Eitzman, 1979; Cooke et al., 1979; de Cour-
ten & Rabinowicz, 1981; Hill et al., 1982; Lou et al., 
1977: Ment et al., 1981; Wigglesworth et al., 1977). 
Other physiologic maturity factors such as capillary 
integrity (Volpe, 1981) and transmural pressure 
gradients (Conner et al., 1983; Coulter, 1980; 
Goldstein, 1979; Welch, 1980) then determine the 
response to the increase in cerebral blood flow. 
Clinical factors such as hypoxic-ischemic injury to 
the immature cerebral structures further complicate 
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the ability of fragile cerebral vessels and gelatinous 
vascular supporting structures to accomodate a sudden 
increase in cerebral blood flow (Fujimura et al., 
1979; Volpe, 1981). Neonatal germinal matrix hemor-
rhage has also been reported to be a progressive 
lesion (Conner et al., 1983; Donn & Stuck, 1981), 
perhaps due to the reported increase in fibrinolytic 
activity of the periventricular region of the preterm 
infant (Volpe, 1981). 
Variables affecting the occurrence of hyper-
glycemia are also multifactorial in nature. Neuro-
endocrine response (Fisher, 1975; Pollak et al., 1978; 
Salle & Ruitton-Uglienco, 1976; Sherwood & Chance, 
1977), peripheral tissue sensitivity to insulin 
(Goldman & Hirata, 1980; Pollak et al., 1978; Zarif 
et al., 1976), and/or stress (Baum & Porte, 1980; 
Cerchio et al., 1973; Zarif et al., 1976) have all 
been investigated in association with hyperglycemia 
in the preterm infant. 
The multitude of components involved in deter-
mining the extent of a PV-IVH and/or hyperglycemia 
is unique to each individual and mayor may not be 
interrelated. These reports would therefore lend 
support to the lack of correlation in this study 
sample between the degree of hyperglycemia and the 
subsequent grade of the PV-IVH. 
Research Question Three 
Is the degree of hyperglycemia, regard-
less of the grade of PV-IVH, related 
to the development of posthemorrhagic 
hydrocephalus (PHH)? . 
The relationship between the degree of hyper-
glycemia and the development of posthemorrhagic 
hydrocephalus (PHH) was analyzed by descriptive 
statistics and the Mann-Whitney U test. Information 
collected to determine the surgical placement of a 
ventriculo-peritoneal shunt (used to define PHH in 
this study) (Table 5) was obtained from the patient's 
medical records. The Mann-Whitney U analysis showed 
no significant relationship between the severity of 
hyperglycemia and the subsequent necessity for a 
shunt (Table 11). 
The incidence of PHH in the literature was 
varied. This discrepancy in the reported incidence 
is most likely due to the technological advances made 
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in ultrasonography which has facilitated the diagnosis 
and follow-up on ventricular dilatation, as well as 
the development of hydrocephalus. Current studies 
report a 20-35% incidence of PHH as detected by 
echoencephalogram (Ahmann et al., 1980; Levene & 
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Studies have repeatedly demonstrated that serial 
occipitalfrontal circumferences are poor determinants 
of early PHH (Ahmann et al., 1980; Bridgers & Ment, 
1981; Papile et al., 1980). In careful ultrasono-
graphic follow-up of posthemorrhagic ventricular 
dilatation, most cases are found to spontaneously 
resolve and not require surgical shunting procedures 
(Ahmann et al., 1980; Levene & Etarte, 1981). These 
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reports served as the basis for defining PHH in this 
study sample as infants requiring a ventriculo-periton-
eal shunt. 
PV-IVH has been described as being a progressive 
lesion (Connor et al., 1983; Donn & Stuck, 1981) and 
a significant relationship seemed to exist between 
the quantification of hemorrhage to the development 
of PHH. Therefore, one may speculate that the initial 
protein content of CSF may be more predictive of the 
subsequent need for a shunt,. rather than the degree 
of hyperglycemia. As described in the previous section 
(research question two), a multitude of factors are 
involved in the pathogenetic mechanisms of hypergly-
cemia as well as PV-IVH. Thus, information gathered 
from this study sample could not demonstrate a 
relationship between severity of hyperglycemia and 
subsequent need for a shunt. 
CHAPTER V 
SUMMARY, CONCLUSIONS AND 
RECOMMENDATIONS 
Summary 
The purpose of this study was to determine the 
relationship between the onset of PV-IVH and the occur-
rence of hyperglycemia. However, recovering information 
from the charts required to pinpoint the onset of the 
PV-IVH, presented major difficulties to this study. 
The information gathered from the patient's charts 
was, therefore, examined only to identify if an 
association between the variables of PV-IVH and hyper-
glycemia were related. 
The General Systems Theory was the basis for 
this study's conceptual framework. When the mutually 
interacting systems within the human body experience 
a stress, the preservation of an intact system may 
potentially be facilitated by nurses, who identify 
the disturbance. The proposed mechanism of stress, 
hyperglycemia and/or PV-IVH was presented. 
The review of literature demonstrated the high 
incidence of PV-IVH in the preterm infant. Several 
studies identifying risk factors associated with PV-
IVH were presented. Various proposals on etiologic 
factors of neonatal hyperglycemia were reviewed. 
Studies potentially linking hyperglycemia with PV-IVH 
were also available for examination. If a relationship 
between glucose intolerance and PV-IVH could be 
demonstrated, hyperglycemia may in the future give 
warning to a new or impending PV-IVH. This would 
facilitate the prompt initiation of therapy to 
provide optimal survival of these infants. 
The study sample consisted of 57 preterm infants 
from the University of Utah Medical Center's NICU 
who were diagnosed with hyperglycemia, PV-IVH or 
hyperglycemia and PV-IVH. A retrospective review 
of their medical records was conducted for this 
investigation. 
The first research question was modified to deter-
mine if an association between the variables of hyper-
glycemia and PV-IVH are related. Identification of 
the onset of PV-IVH was not possible in this study. 
The determination of risk of the stress indicators 
occurring with the variables of hyperglycemia and 
PV-IVH was conducted. Ventilatory support and the 
development of a pneumothorax were significantly 
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correlated with the occurrence of a PV-IVH. Cardio-
pulmonary deterioration was statistically significant 
and ventilatory support only weakly significant in 
relationship to the occurrence of hyperglycemia. 
Overall, the data analysis demonstrated a significant 
risk for the development of hyperglycemia in relation-
ship to PV-IVH. 
The second research question examined the relation-
ship between the degree of glucose intolerance to the 
grade of PV-IVH experienced. No significant correlation 
was demonstrated between the degree of glucose 
intolerance to the subsequent grade of PV-IVH. The 
occurrence of a PV-IVH however, was statistically 
significant in association with a hyperglycemic episode 
occurring in the clinical course of this preterm study 
sample. 
Research question three attempted to describe a 
relationship between the degree of glucose intolerance 
and the subsequent development of PHH (defined as 
needing a ventriculo-peritoneal shunt). There was no 
significant relationship between the severity of 
hyperglycemia and the subsequent need for a shunt. 
Conclusions 
The findings from this study suggest that a _ 
relationship may exist between hyperglycemia and 
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PV-IVH. The clinical value of glucose determinations 
may serve to identify a new or impending PV-IVH. The 
severity of hyperglycemia cannot predict the extent 
of a PV-IVH or the subsequent need for a ventriculo-
peritoneal shunt. A controlled prospective study with 
a larger study sample may provide information to 
validate this relationship. If the relationship 
between hyperglycemia and PV-IVH can be demonstrated, 
nurses may be able to utilize the glucose value {or 
Dextrosti~ as a tool to identify infants at risk for 
PV-IVH or intervene to prevent complications of a newly 
occurred PV-IVH. The overall contribution of this 
study exists in its capacity to expand the knowledge 
base of this serious neonatal complication. 
Recommendations 
Recommendations for further research include: 
1. Conduct a prospective study with a large 
sample size, controlling for confounding 
variables and providing a consistent measure-
ment of serum glucose values and echoence-
phalographic imaging. 
2. A continuous, noninvasive method of measuring 
cerebral blood flow could be utilized to 
examine this factor in relationship to serum 
glucose levels and the occurrence of PV-IVH. 
3. A continuous method of measuring serum 
glucose values would facilitate the identifi-
cation of blood glucose fluctuations in 
response to a variety of clinical stress 
factors associated with a preterm infant. 
4. Continuous measurement of arterial and/or 
peripheral blood pressure values correlated 
with cerebral blood flow and/or serum 
glucose values would further clarify the 
relationship among these variables. 
5. Measurement of other substrates reflective 
of a stress response such as urine cate-
cholamine levels to determine if hyper-
glycemia is a response to stress. 
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